Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > University research scoops Innovation Awards

Abstract:
UniQuest Pty Limited, The University of Queensland's (UQ) main commercialisation company, congratulates Professor Mark Kendall and his Nanopatch research team at the Australian Institute for Bioengineering and Nanotechnology on being awarded the overall prize and Manufacturing and High-tech Design category winner of The Australian's inaugural Innovation Challenge.

University research scoops Innovation Awards

St Lucia, Australia | Posted on December 21st, 2011

The revolutionary vaccine delivery technology is one of three UQ research-based innovations associated with UniQuest to have been selected in the short-list of 35 Professional Category finalists for the $75,000 awards program.

UniQuest Managing Director, David Henderson, said the awards capped off a year of significant milestones for the Nanopatch research and commercialisation teams, including winning the Eureka Prize for Research by an Interdisciplinary Team.

"In August Vaxxas Pty Ltd, the start-up company established to commercialise the Nanopatch technology, secured a A$15 million investment from a syndicate of Australian and international venture capital funds," Mr Henderson explained.

"The deal was one of Australia's largest first round start-up investments in a university technology, the first investment for syndicate members OneVentures, Brandon Capital and the Medical Research Commercialisation Fund in Queensland, and the first investment in Australia for US-based Healthcare Ventures.

"Winning The Australian's inaugural Innovation Challenge is a further endorsement of the value our universities are contributing, not only to the national innovation economy and reputation, but also to the health of communities all around the world."

Smaller than a postage stamp and working via the skin, the Nanopatch is expected to change the way vaccines are delivered in the future, particularly in developing countries. As well as potentially eliminating pain associated with injection and refrigeration requirements, and reducing the cost of many syringe-delivered vaccines, the Nanopatch has the potential to dramatically improve patient convenience, reduce the complications associated with needle phobia, and address key global health issues of needle stick injuries and cross contamination.

Another vaccine breakthrough to make the finals in the Health category is being developed by Professor Ranjeny Thomas and her team at the UQ Diamantina Institute. Caused by immune system dysfunction, rheumatoid arthritis (RA) affects millions of people worldwide, destroying joints and causing cardiovascular complications that can reduce life spans by 10 years. Professor Ranjeny's innovation targets the underlying cause of the disease, rather than the symptoms, potentially avoiding common side effects of existing immunosuppressant drug therapies, such as infection susceptibility.

In the Environment category, Dr Laurence Rossato and her research team in UQ's Centre for Mined Land Rehabilitation received recognition when their technology for promoting vegetation growth at mine sites contaminated by heavy metals was selected as a finalist. This innovation also recently won a 2011 Australia Mining Prospect Award for Excellence in Environmental Management.

Mr Henderson said the publicity arising from awards programs like the Innovation Challenge can be helpful in attracting commercial partners for university research projects.

"Australians are always very proud of ‘home-grown' inventions, whether they are borne from a backyard shed or discovered in our world-class scientific research facilities. We're proud to have helped the researchers develop their ideas to the point where they can be recognised as new products offering both a financial and a societal return on investment."

####

About UniQuest Pty Limited
Established by The University of Queensland in 1984, UniQuest is widely recognised as one of Australia’s largest and most successful university commercialisation groups, benchmarking in the top tier of technology transfer worldwide. From an intellectual property portfolio of 1,500+ patents it has created over 60 companies, and since 2000 UniQuest and its start-ups have raised more than $400 million to take university technologies to market. Annual sales of products using UQ technology and licensed by UniQuest are running at $3 billion. UniQuest now commercialises innovations developed at The University of Queensland and its commercialisation partner institutions: the University of Wollongong, University of Technology Sydney, James Cook University, University of Tasmania, Mater Medical Research Institute, and Queensland Health. UniQuest also provides access to an expansive and exclusive network of independent academics to tailor a consulting or project R&D solution to meet the diverse needs of industry and government, facilitating some 500 consulting, expert opinion, testing, and contract research services each year.
UniQuest is also a leading Australasian provider of international development assistance recognised for excellence in technical leadership, management and research. Working with agencies such as AusAID, NZAID, the Asian Development Bank and the World Bank, UniQuest has developed and implemented more than 400 projects in 46 countries throughout the Pacific, South-East Asia, the Indian sub-continent and Africa.

For more information, please click here

Contacts:
Leanne Wyvill
Ph: +61 7 3365 4037
Mob: +61 0 409767199

Copyright © UniQuest Pty Limited

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Academic/Education

Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024

Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022

National Space Society Helps Fund Expanding Frontier’s Brownsville Summer Entrepreneur Academy: National Space Society and Club for the Future to Support Youth Development Program in South Texas June 24th, 2022

How a physicist aims to reduce the noise in quantum computing: NAU assistant professor Ryan Behunin received an NSF CAREER grant to study how to reduce the noise produced in the process of quantum computing, which will make it better and more practical April 1st, 2022

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Discovery of new Li ion conductor unlocks new direction for sustainable batteries: University of Liverpool researchers have discovered a new solid material that rapidly conducts lithium ions February 16th, 2024

$900,000 awarded to optimize graphene energy harvesting devices: The WoodNext Foundation's commitment to U of A physicist Paul Thibado will be used to develop sensor systems compatible with six different power sources January 12th, 2024

Catalytic combo converts CO2 to solid carbon nanofibers: Tandem electrocatalytic-thermocatalytic conversion could help offset emissions of potent greenhouse gas by locking carbon away in a useful material January 12th, 2024

'Sudden death' of quantum fluctuations defies current theories of superconductivity: Study challenges the conventional wisdom of superconducting quantum transitions January 12th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project